Clinical Safety Study for Continuous Intake of Beta-Glucan polysaccharide and Beta-Glucan oligosaccharide from Ophiocordyceps dipterigena BCC 2073 in healthy volunteers

Institute of Nutrition, Mahidol University0 个研究点目标入组 96 人开始时间: 2024年6月22日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. 20-55 years old, 2. healthy with no systemic diseases, 3. BMI less than 30 kg/m2, 4. acceptable normal blood biochemical parameters (hemoglobin 11-16 gm/ dL for female or 12-18 gm/dL for male, white blood cells 4,000 to 10,000 cells/mm3, asting plasma glucose no more than 125 mg/dL, HbA1c no more than 5.8 percent, total cholesterol/ HDL ratio no more than 5.1, ALT no more than 60 U/L, eGFR at least 90 mL/min/ 1.73 m2), 5. acceptable normal blood pressure (diastolic pressure 60-90 mm Hg, systolic pressure 90-140 mm Hg), 6. normal heart rate (no more than 100 times/ min)

•1.History of COVID-19 infection or exposure, 2. History of allergy to Cordyceps or other herbs, 3. Unable to follow-up every 4 weeks, 4. Pregnant or plan to get pregnant within 3 months, 5. Regular consumption of drugs, herbs or dietary supplements, 6. Breastfeeding, 7. alcohol intake > 14 drinks per week for male or > 7 drinks per week for females and cannot refrain from alcohol intake during the study, 8. smoking > 10 cigarettes/day, 9. Bleeding problems e.g. idiopathic thrombocytopenia, 10. Having certain conditions not suitable to consume beta-glucans e.g. severe gastrointestinal diseases

发起方

Institute of Nutrition, Mahidol University